Wosulin R 40iu Vial 10ml

Wosulin R 40IU Injection is a short-acting human insulin used to manage blood sugar levels in patients with type 1 and type 2 diabetes mellitus. It mimics the insulin produced by the pancreas, facilitating glucose uptake by muscle and fat cells and suppressing glucose production in the liver. This helps control postprandial hyperglycemia (rise in blood sugar after meals) and prevents diabetes-related complications such as kidney damage, blindness, nerve problems, and limb loss.

Composition:

• Regular Human Insulin: 40 IU/ml – A synthetic insulin that mimics natural insulin to regulate blood sugar.
• M-Cresol: 0.25% – Acts as a preservative to maintain the solution’s sterility and stability.

Uses:

• Treatment of type 1 diabetes (where the body does not produce insulin).
• Treatment of type 2 diabetes (where the body does not produce enough insulin or is resistant to it).
• Helps control blood sugar levels after meals when used with a healthy diet and regular exercise.

Often prescribed with long-acting insulin or other diabetes medications.

Mechanism of Action:
Wosulin R is a rapid-acting insulin that starts working within 10–30 minutes after injection, with effects lasting 3–8 hours. It binds to insulin receptors, promoting glucose uptake by cells and inhibiting liver glucose production, thus lowering blood sugar levels.

Administration:

• Route: Subcutaneous injection (under the skin) in the abdomen, thigh, upper arm, or buttock.
• Timing: Administer 5–30 minutes before a meal or immediately after food, as advised by a doctor.
• Technique: Rotate injection sites to prevent lipodystrophy (skin thickening or pits). Pinch the skin, inject at a 45° angle, and hold the needle for at least 6 seconds to ensure complete delivery.

Dosage: Determined by a doctor based on blood sugar levels and individual response. Regular monitoring is essential for dose adjustments

 

Storage:

• Store in a refrigerator at 2–8°C (do not freeze).
• Opened vials can be kept at room temperature (up to 25°C) for up to 4 weeks.

Keep away from direct heat and light.

Side Effects:
Common side effects (usually temporary and resolve over time):

• Hypoglycemia (low blood sugar): Symptoms include sweating, shakiness, hunger, rapid heartbeat, weakness, or blurred vision.
• Injection site reactions: Pain, redness, swelling, or itching.
• Lipodystrophy: Thickening or thinning of skin at injection sites.
• Hypokalemia: Low potassium levels, causing weakness or heart palpitations.
• Allergic reactions: Rash, itching, or swelling (rare).
• Oedema: Swelling due to fluid retention.
• Weight gain.
  Consult a doctor if side effects persist or worsen. Severe hypoglycemia requires immediate medical attention.

 

Precautions:

• Contraindications: Do not use if allergic to human insulin or during hypoglycemic episodes.
• Medical Conditions: Use with caution in patients with kidney, liver, or heart problems, or a history of stroke.
• Hypoglycemia Risk: Avoid skipping meals or overdosing. Carry a snack or glucose source to manage low blood sugar.
• Alcohol: Avoid alcohol, as it may alter blood sugar levels.
• Travel: Consult a doctor when traveling across time zones, as meal and injection schedules may need adjustment.
• Pregnancy/Breastfeeding: Generally safe but requires doctor consultation and regular glucose monitoring.
• Driving: Avoid driving if experiencing low or high blood sugar symptoms, as it may impair alertness.

Drug Interactions:

• May interact with other antidiabetic agents, increasing hypoglycemia risk (e.g., thiazolidinediones, acarbose).
• Medications like beta-blockers, ACE inhibitors, or antidepressants may mask hypoglycemia symptoms or alter insulin effects.
• Inform your doctor about all medications, including over-the-counter drugs and supplements.

Additional Notes:

• A prescription is required.
• Regular blood sugar monitoring is crucial to avoid complications.
• Follow a healthy diet, exercise regularly, and maintain a healthy weight as part of the treatment plan.
• Consult a healthcare professional for proper injection training if self-administering.